Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-25-318663
Filing Date
2025-12-15
Accepted
2025-12-15 10:17:14
Documents
6
Period of Report
2025-12-15

Document Format Files

Seq Description Document Type Size
1 6-K d817121d6k.htm 6-K 8562
2 EX-99.1 d817121dex991.htm EX-99.1 15326
3 EX-99.2 d817121dex992.htm EX-99.2 21994
4 GRAPHIC g817121g1215155037883.jpg GRAPHIC 2601
5 GRAPHIC g817121g1215155211570.jpg GRAPHIC 2601
6 GRAPHIC g817121g1215174610493.jpg GRAPHIC 1302
  Complete submission text file 0001193125-25-318663.txt   56520
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

EIN.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 251570308
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)